LncRNA GAS5 Modulates the Progression of Glioma Through Repressing miR-135b-5p and Upregulating APC

References

• Weller M, Wick W, Aldape K. et al. Glioma. Nat Rev Dis Primers. 2015;1(1):15017. doi:10.1038/nrdp.2015.17
   PubMed Web of Science ®Google Scholar
• Chen R, Smith-Cohn M, Cohen AL, Colman H. Glioma subclassifications and their clinical significance. Neurotherapeutics. 2017;14(2):284–297. doi:10.1007/s13311-017-0519-x
   PubMed Web of Science ®Google Scholar
• Zhu XP, Pan SA, Chu Z, Zhou YX, Han DQ, Han D-Q. LncRNA GAS5 regulates epithelial-mesenchymal transition and viability of glioma cells by targeting microRNA-106b and regulating PTEN expression. Neurosci Res. 2020;170:32–40. doi:10.1016/j.neures.2020.08.009
   PubMed Web of Science ®Google Scholar
• Le VH, Minh TNT, Kha QH, Le NQK. A transfer learning approach on MRI-based radiomics signature for overall survival prediction of low-grade and high-grade gliomas. Med Biol Eng Comput. 2023;61(10):2699–2712. doi:10.1007/s11517-023-02875-2
   PubMedGoogle Scholar
• Bondy ML, Scheurer ME, Malmer B, et al. Brain tumor epidemiology: consensus from the brain tumor epidemiology consortium. Cancer. 2008;113(S7):1953–1968. doi:10.1002/cncr.23741
   PubMedGoogle Scholar
• Connelly JM, Malkin MG. Environmental risk factors for brain tumors. Curr Neurol Neurosci Rep. 2007;7(3):208–214. doi:10.1007/s11910-007-0032-4
   PubMed Web of Science ®Google Scholar
• Ostrom QT, Barnholtz-Sloan JS. Current state of our knowledge on brain tumor epidemiology. Curr Neurol Neurosci Rep. 2011;11(3):329–335. doi:10.1007/s11910-011-0189-8
   PubMed Web of Science ®Google Scholar
• Shete S, Hosking FJ, Robertson LB, et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet. 2009;41(8):899–904. doi:10.1038/ng.407
   PubMed Web of Science ®Google Scholar
• Wrensch M, Jenkins RB, Chang JS, et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet. 2009;41(8):905–908. doi:10.1038/ng.408
   PubMed Web of Science ®Google Scholar
• Walsh KM, Codd V, Smirnov IV, et al. Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk. Nat Genet. 2014;46(7):731–735. doi:10.1038/ng.3004
   PubMed Web of Science ®Google Scholar
• Rajaraman P, Melin BS, Wang Z, et al. Genome-wide association study of glioma and meta-analysis. Hum Genet. 2012;131(12):1877–1888. doi:10.1007/s00439-012-1212-0
   PubMed Web of Science ®Google Scholar
• Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97–109. doi:10.1007/s00401-007-0243-4
   PubMed Web of Science ®Google Scholar
• Li X, Guan J, Jiang Z, Cheng S, Wang Z. Microglial exosome miR-7239-3p promotes glioma progression by regulating circadian genes. Bulle Neurosci. 2021;37(4):497–510. doi:10.1007/s12264-020-00626-z
   PubMed Web of Science ®Google Scholar
• Nabors LB, Portnow J, Ammirati M, et al. NCCN guidelines insights: central nervous system cancers, version 1.2017. J Natl Compr Canc Netw. 2017;15(11):1331–1345. doi:10.6004/jnccn.2017.0166
   PubMed Web of Science ®Google Scholar
• Ghantasala S, Gollapalli K, Epari S, Moiyadi A, Srivastava S. Glioma tumor proteomics: clinically useful protein biomarkers and future perspectives. Expert Rev Proteomics. 2020;17(3):221–232. doi:10.1080/14789450.2020.1731310
   PubMed Web of Science ®Google Scholar
• Didier M, Kinan DA, Andre N, Ivan B, Antonin M. Long noncoding RNAs as new architects in cancer epigenetics, prognostic biomarkers, and potential therapeutic targets. Biomed Res Int. 2015;2015:320214. doi:10.1155/2015/320214
   PubMed Web of Science ®Google Scholar
• Liu B, Wu S, Ma J, et al. lncrna gas5 reverses emt and tumor stem cell- mediated gemcitabine resistance and metastasis by targeting mir-221/socs3 in pancreatic cancer. Mol Ther Nucleic Acids. 2018;13:472–482. doi:10.1016/j.omtn.2018.09.026
   PubMedGoogle Scholar
• Yue Q, Zhao C, Wang Y, et al. Downregulation of growth arrest-specific transcript 5 alleviates palmitic acid-induced myocardial inflammatory injury through the miR26a/HMGB1/NFκB axis. Molecu Med rep. 2018;18(6):5742–5750. doi:10.3892/mmr.2018.9593
   PubMed Web of Science ®Google Scholar
• Dai SP, Jin J, Li WM. Diagnostic efficacy of long non-coding RNA in lung cancer: a systematic review and meta-analysis. Postgrad Med J. 2018;94(1116):578–587. doi:10.1136/postgradmedj-2018-135862
   PubMed Web of Science ®Google Scholar
• Yang X, Xie Z, Lei X, Gan R. Long noncoding RNA GAS5 in human cancer (Review). Oncol Lett. 2020;20(3):2587–2594. doi:10.3892/ol.2020.11809
   PubMed Web of Science ®Google Scholar
• Juan G, Yueping W, Xuedong W, et al. Effect of the LncRNA GAS5-MiR-23a-ATG3 axis in regulating autophagy in patients with breast cancer. Cell Physiol Biochem. 2018;48(1):194–207. doi:10.1159/000491718
   PubMedGoogle Scholar
• Liu J, Chen M, Ma L, Dang X, Du G. LncRNA GAS5 suppresses the proliferation and invasion of osteosarcoma cells via the miR-23a-3p/PTEN/PI3K/AKT pathway. Cell Transplan. 2020;29:1182–1188. doi:10.1177/0963689720953093
   Web of Science ®Google Scholar
• Bahubeshi A, Tischkowitz M, Foulkes WD. miRNA processing and human cancer: DICER1 cuts the mustard. Sci trans med. 2011;3(111):111ps146. doi:10.1126/scitranslmed.3002493
   Web of Science ®Google Scholar
• Chou CH, Shrestha S, Yang CD, et al. miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucleic Acids Res. 2018;46(D1):D296–D302. doi:10.1093/nar/gkx1067
   PubMed Web of Science ®Google Scholar
• Võsa U, Vooder TN, Kolde R, et al. Identification of MiR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer. Genes Chromosomes Cancer. 2011;50(10):812–822. doi:10.1002/gcc.20902
   PubMed Web of Science ®Google Scholar
• Zhang Z, Li J, Huang Y. Upregulated miR-1258 regulates cell cycle and inhibits cell proliferation by directly targeting E2F8 in CRC. Cell Proliferation. 2018;51(6):e12505. doi:10.1111/cpr.12505
   PubMed Web of Science ®Google Scholar
• Robertis MD, Poeta ML, Signori E, et al. Current understanding and clinical utility of miRNAs regulation of colon cancer stem cells. Semi Cancer Biol. 2018;53:232–247. doi:10.1016/j.semcancer.2018.08.008
   PubMed Web of Science ®Google Scholar
• Akcakaya P, Ekelund S, Kolosenko I. Ak�akaya. miR-185 and miR-133b deregulation is associated with overall survival and metastasis in colorectal cancer. Int j Oncol. 2011;39(2):311–318. doi:10.3892/ijo.2011.1043
   PubMed Web of Science ®Google Scholar
• Wen SY, Lin Y, Yu YQ, Cao SJ, Zhang ZG. miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer. Oncogene. 2014;34(6):717–725. doi:10.1038/onc.2014.9
   PubMed Web of Science ®Google Scholar
• Nagel R, le Sage C, Diosdado B, et al. Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. Cancer Res. 2008;68(14):5795–5802. doi:10.1158/0008-5472.CAN-08-0951
   PubMed Web of Science ®Google Scholar
• Chen Z, Gao Y, Gao S, Song D, Feng Y. MiR-135b-5p promotes viability, proliferation, migration and invasion of gastric cancer cells by targeting Krüppel-like factor 4 (KLF4). Arch Med Sci. 2020;16(1):167–176. doi:10.5114/aoms.2019.87761
   PubMed Web of Science ®Google Scholar
• Li L, Wang A, Cai M, Tong M, Chen F, Huang L. Identification of stool miR-135b-5p as a non-invasive diagnostic biomarker in later tumor stage of colorectal cancer. Life Sci. 2020;260:118417. doi:10.1016/j.lfs.2020.118417
   PubMed Web of Science ®Google Scholar
• Bodmer WF, Bailey CJ, Bodmer J, et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature. 1987;328(6131):614–616. doi:10.1038/328614a0
   PubMed Web of Science ®Google Scholar
• Kinzler KW, Nilbert MC, Su LK, et al. Identification of FAP locus genes from chromosome 5q21. Science. 1991;253(5020):661–665. doi:10.1126/science.1651562
   PubMed Web of Science ®Google Scholar
• Senda T, Shimomura A, Iizuka-Kogo A. Adenomatous polyposis coli (APC) tumor suppressor gene as a multifunctional gene. Anat Sci Int. 2005;80(3):121–131. doi:10.1111/j.1447-073x.2005.00106.x
   PubMedGoogle Scholar
• Stefanski CD, Prosperi JR. Wnt-independent and wnt-dependent effects of APC loss on the chemotherapeutic response. Int J Mol Sci. 2020;21(21):7844. doi:10.3390/ijms21217844
   PubMed Web of Science ®Google Scholar
• Carothers AM, Melstrom KA, Mueller JD, Weyant MJ, Bertagnolli MM. Progressive changes in adherens junction structure during intestinal adenoma formation in APC mutant mice. J Biol Chem. 2001;276(42):39094–39102. doi:10.1074/jbc.M103450200
   PubMed Web of Science ®Google Scholar
• Hankey W, Frankel WL, Groden J. Functions of the APC tumor suppressor protein dependent and independent of canonical WNT signaling: implications for therapeutic targeting. Cancer Metastasis Rev. 2018;37(1):159–172. doi:10.1007/s10555-017-9725-6
   PubMed Web of Science ®Google Scholar
• Aoki K, Taketo MM. Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene. J Cell Sci. 2007;120(19):3327–3335. doi:10.1242/jcs.03485
   PubMed Web of Science ®Google Scholar
• van den Broek E, Krijgsman O, Sie D, et al. Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients. Oncotarget. 2016;7(45):73876–73887. doi:10.18632/oncotarget.12510
   PubMedGoogle Scholar
• Zhang X, Zhang X. MicroRNA-135b-5p regulates trophoblast cell function by targeting phosphoinositide-3-kinase regulatory subunit 2 in preeclampsia. Bioengineered. 2022;13(5):12338–12349. doi:10.1080/21655979.2022.2073655
   PubMed Web of Science ®Google Scholar
• Zhang XH, Xin ZM. MiR-135b-5p inhibits the progression of malignant melanoma cells by targeting RBX1. Eur Rev Med Pharmacol Sci. 2020;24(3):1309–1315. doi:10.26355/eurrev_202002_20188
   PubMed Web of Science ®Google Scholar
• Liu D, Jin Y, Wu J, Zhu H, Ye D. MiR-135b-5p is an oncogene in pancreatic cancer to regulate GPRC5A expression by targeting transcription factor KLF4. Cell Death Discov. 2022;8(1):23–34. doi:10.1038/s41420-022-00814-y
   PubMed Web of Science ®Google Scholar
• Zhao CC, Jiao Y, Zhang YY, et al. Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt/β-catenin pathway by sponging miR-135b-5p to elevate expression of APC. Cell Death Dis. 2019;10(4):252–266. doi:10.1038/s41419-019-1479-3
   PubMed Web of Science ®Google Scholar
• Gusyatiner O, Hegi ME. Glioma epigenetics: from subclassification to novel treatment options. Semi Cancer Biol. 2018;51:50–58. doi:10.1016/j.semcancer.2017.11.010
   PubMed Web of Science ®Google Scholar
• Ostrom QT, Luc B, Davis FG, et al. The epidemiology of glioma in adults: a “state of the science” review. Neuro-Oncology. 2014;16(7):896–913. doi:10.1093/neuonc/nou087
   PubMed Web of Science ®Google Scholar
• Louis DN, Perry A, Wesseling P, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23(8):1231–1251. doi:10.1093/neuonc/noab106
   PubMed Web of Science ®Google Scholar
• Stupp R, Taillibert S, Kanner A, et al. Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial. JAMA. 2017;318(23):2306–2316. doi:10.1001/jama.2017.18718
   PubMed Web of Science ®Google Scholar
• Sathornsumetee S, Reardon DA, Desjardins A, Quinn JA, Vredenburgh JJ, Rich JN. Molecularly targeted therapy for malignant glioma. Cancer. 2007;110(1):13–24. doi:10.1002/cncr.22741
   PubMed Web of Science ®Google Scholar
• Zhu XP, Pan SA, Chu Z, Zhou YX, Huang YK, Han DQ. LncRNA GAS5 regulates epithelial-mesenchymal transition and viability of glioma cells by targeting microRNA-106b and regulating PTEN expression. Neurosci Res. 2021;170:32–40.
   PubMed Web of Science ®Google Scholar
• Chen L, Ren P, Zhang Y, Gong B, Yu D, Sun X. Long non‑coding RNA GAS5 increases the radiosensitivity of A549 cells through interaction with the miR‑21/PTEN/Akt axis. Oncol Rep. 2020;43(3):897–907. doi:10.3892/or.2020.7467
   PubMed Web of Science ®Google Scholar
• Ma J, Miao H, Zhang H, et al. LncRNA GAS5 modulates the progression of non-small cell lung cancer through repressing miR-221-3p and up-regulating IRF2. Diagn Pathol. 2021;16(1):46–54. doi:10.1186/s13000-021-01108-0
   PubMed Web of Science ®Google Scholar
• Wang H, Wang D, Shen Y, et al. GAS5 attenuates the malignant progression of glioma stem-like cells by promoting E-cadherin. Cancer Genet Ther. 2023;30(3):450. doi:10.1038/s41417-022-00566-y
   PubMed Web of Science ®Google Scholar
• Zhao X, Wang P, Liu J, et al. Gas5 Exerts Tumor-suppressive functions in human glioma cells by targeting miR-222. Mol Ther. 2015;23(12):1899–1911. doi:10.1038/mt.2015.170
   PubMed Web of Science ®Google Scholar
• Wang Y, Xin S, Zhang K, Shi R, Bao X. Low GAS5 levels as a predictor of poor survival in patients with lower-grade gliomas. J Oncol. 2019;2019:1–15.
   Web of Science ®Google Scholar
• Duan XM, Liu XN, Li YX, et al. MicroRNA-498 promotes proliferation, migration, and invasion of prostate cancer cells and decreases radiation sensitivity by targeting PTEN. Kaohsiung J Med Sci. 2019;35(11):659–671. doi:10.1002/kjm2.12108
   PubMed Web of Science ®Google Scholar
• Su P, Mu S, Wang Z. Long noncoding RNA SNHG16 promotes osteosarcoma cells migration and invasion via sponging miRNA-340. DNA Cell Biol. 2019;38(2):170–175. doi:10.1089/dna.2018.4424
   PubMed Web of Science ®Google Scholar
• Peng W, Deng W, Zhang J, Pei G, Rong Q, Zhu S. Long noncoding RNA ANCR suppresses bone formation of periodontal ligament stem cells via sponging miRNA-758. Biochem Biophys Res Commun. 2018;503(2):815–821. doi:10.1016/j.bbrc.2018.06.081
   PubMed Web of Science ®Google Scholar
• Rezaei O, Tamizkar KH, Sharifi G, Taheri M, Ghafouri-Fard S. Emerging Role of Long Non-Coding RNAs in the Pathobiology of Glioblastoma. Front Oncol. 2021;10:625884. doi:10.3389/fonc.2020.625884
   PubMed Web of Science ®Google Scholar
• Dong L, Li G, Li Y, Zhu Z. Upregulation of long noncoding RNA GAS5 inhibits lung cancer cell proliferation and metastasis via miR-205/PTEN axis. Med Sci Monit. 2019;25:2311–2319. doi:10.12659/MSM.912581
   PubMed Web of Science ®Google Scholar
• Jin C, Zhao J, Zhang ZP, Wu M, Liu JP. Long non-coding RNA GAS5, by up-regulating PRC2 and targeting the promoter methylation of miR-424, suppresses multiple malignant phenotypes of glioma. J Neuro-oncol. 2020;148(3):529–543. doi:10.1007/s11060-020-03544-2
   PubMed Web of Science ®Google Scholar
• Lin CW, Chang YL, Chang YC, et al. MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1. Nat Commun. 2013;4(1):1877–1890. doi:10.1038/ncomms2876
   PubMedGoogle Scholar
• Zhang L, Sun ZJ, Bian Y, Kulkarni AB. MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma. Cancer Lett. 2013;331(2):230–238. doi:10.1016/j.canlet.2013.01.003
   PubMed Web of Science ®Google Scholar
• Wang N, Tao L, Zhong H, et al. miR-135b inhibits tumour metastasis in prostate cancer by targeting STAT6. Oncol Lett. 2016;11(1):543–550. doi:10.3892/ol.2015.3970
   PubMed Web of Science ®Google Scholar
• Su W, Mo Y, Wu F, et al. miR-135b reverses chemoresistance of non-small cell lung cancer cells by downregulation of FZD1. Biomed Pharmacother. 2016;84:123–129. doi:10.1016/j.biopha.2016.09.027
   PubMed Web of Science ®Google Scholar
• Lulli V, Buccarelli M, Martini M, et al. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal. Oncotarget. 2015;6(35):37241–37256. doi:10.18632/oncotarget.5925
   PubMedGoogle Scholar
• Wang Q, Cao T, Guo K, et al. Regulation of integrin subunit alpha 2 by miR-135b-5p modulates chemoresistance in gastric cancer. Front Oncol. 2020;10:308–319. doi:10.3389/fonc.2020.00308
   PubMed Web of Science ®Google Scholar
• Li P, Fan JB, Gao Y, et al. miR-135b-5p inhibits LPS-induced TNFα production via silencing AMPK phosphatase Ppm1e. Oncotarget. 2016;7(47):77978–77986. doi:10.18632/oncotarget.12866
   PubMedGoogle Scholar
• Jin H, Luo S, Wang Y, et al. miR-135b stimulates osteosarcoma recurrence and lung metastasis via notch and wnt/β-catenin signaling. Mol Ther Nucleic Acids. 2017;8:111–122. doi:10.1016/j.omtn.2017.06.008
   PubMedGoogle Scholar
• Xu M, Liu X, Xu Y, Zhu S, Gao Y. Co‑expression of Axin and APC gene fragments inhibits colorectal cancer cell growth via regulation of the wnt signaling pathway. Mol Med Rep. 2017;16(4):3783–3790. doi:10.3892/mmr.2017.7049
   PubMed Web of Science ®Google Scholar
• Schweigert A, Fischer C, Mayr D, von Schweinitz D, Kappler R, Hubertus J. Activation of the Wnt/β-catenin pathway is common in Wilms tumor, but rarely through β-catenin mutation and APC promoter methylation. Pediatr Surg Int. 2016;32(12):1141–1146. doi:10.1007/s00383-016-3970-6
   PubMed Web of Science ®Google Scholar
• Lee E, Salic A, Krüger R, Heinrich R, Kirschner MW. The roles of APC and Axin derived from experimental and theoretical analysis of the Wnt pathway. PLoS Biol. 2003;1(1):E10–E26. doi:10.1371/journal.pbio.0000010
   PubMed Web of Science ®Google Scholar
• Jiang D, Zhou B, Xiong Y, Cai H. [Corrigendum] miR‑135 regulated breast cancer proliferation and epithelial‑mesenchymal transition acts by the Wnt/β‑catenin signaling pathway. Int J Mol Med. 2022;50(2):105–107. doi:10.3892/ijmm.2022.5161
   PubMedGoogle Scholar
• Wang LP, Ma XQ, Cai JC. Clinicopathological significance and function of miR-135b in the occurrence and development of gastric cancer. Zhonghua Yi Xue Za Zhi. 2012;92(46):3269–3273.
   PubMedGoogle Scholar